A case study of a graphical misrepresentation: Drawing the wrong conclusions about the measles, mumps and rubella virus vaccine

Drug Safety

Volumn 30, Issue 10, 2007, Pages 831-836

  Cox, Anthony R ^a,b   Kirkham, Harold ^c  

^a CITY HOSPITAL   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

AUTISM; DATA ANALYSIS; DISEASE ASSOCIATION; DRUG INFORMATION; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; PUBLICATION; REVIEW; TREND STUDY; UNITED KINGDOM; UNITED STATES; VACCINATION;

AUTISTIC DISORDER; COMPUTER GRAPHICS; ENGLAND; HUMANS; MEASLES-MUMPS-RUBELLA VACCINE; RESEARCH DESIGN; UNITED STATES;

EID: 34748873139     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200730100-00002     Document Type: Review

References (16)

1. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637-41
2. Fitzpatrick M. MMR and autism: what parents need to know. 1st ed. London: Routledge, 2004
3. Asaria P, MacMahon E. Measles in the United Kingdom: can we eradicate it by 2010? BMJ 2006; 333: 890-5
4. Murch SH, Anthony A, Casson DH, et al. Retraction of an interpretation. Lancet 2004; 363: 750
5. Horton R. The lessons of MMR. Lancet 2004; 363: 747-9
6. The Information Centre. Immunisation statistics England 2005-2006 [online]. Available from URL: http://www.ic.nhs.uk/pubs/immstats2005to2006 [Accessed 2007 Apr 4]
7. Wakefield AJ. MMR vaccination and autism. Lancet 1999; 354: 949-50
8. Department of Developmental Services. Changes in the populations of persons with autism and pervasive developmental disorders in California's Developmental Services System: 1987 through 1998 [online]. Available from URL: http://www.dds.ca.gov/autism/autism_main.cfm [Accessed 2007 Mar 26]
9. Taylor B, Miller E, Farringdon CP, et al. MMR vaccine and autism: no epidemiological evidence for a causal association. Lancet 1999; 353: 2026-9
10. Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in Calfornia. JAMA 2001; 285: 1183-5
11. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002; 347 (19): 1477-82
12. Honda H, Shimizu Y, Rutter M. No effect of MMR withdrawal on the incidence of autism: a total population study. J Child Psychol Psychiatry 2005; 46 (6): 572-9
13. Afzal MA, Ozoemena LC, O'Hare A, et al. Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK. J Med Virol 2006; 78 (5): 623-30
14. D'Souza Y, Fombonne E, Ward BJ. No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autistic spectrum disorder. Pediatrics 2006; 118 (4): 1164-675
15. Global Advisory Committee on Vaccines Safety. MMR and autism [online]. Available from URL: http://www.who.int/vaccine_safety/topics/mmr/mmr_autism/en/ [Accessed 2007 Apr 4]
16. Goodman SN, Altman DG, George SL. Statistical reviewing policies of medical journals, caveat lector? J Gen Intern Med 1998; 13: 753-6